Protagonist Therapeutics, Inc. (PTGX) Cash Flow Quarterly - Discounting Cash Flows
PTGX
Protagonist Therapeutics, Inc.
PTGX (NASDAQ)
Period Ending: LTM
(Last Twelve Months)
2025 (Q3)
09-30
2025 (Q2)
06-30
2025 (Q1)
03-31
2024 (Q4)
12-31
2024 (Q3)
09-30
2024 (Q2)
06-30
2024 (Q1)
03-31
2023 (Q4)
12-31
2023 (Q3)
09-30
2023 (Q2)
06-30
2023 (Q1)
03-31
2022 (Q4)
12-31
2022 (Q3)
09-30
2022 (Q2)
06-30
2022 (Q1)
03-31
2021 (Q4)
12-31
2021 (Q3)
09-30
2021 (Q2)
06-30
2021 (Q1)
03-31
2020 (Q4)
12-31
2020 (Q3)
09-30
2020 (Q2)
06-30
2020 (Q1)
03-31
2019 (Q4)
12-31
2019 (Q3)
09-30
2019 (Q2)
06-30
2019 (Q1)
03-31
2018 (Q4)
12-31
2018 (Q3)
09-30
2018 (Q2)
06-30
2018 (Q1)
03-31
2017 (Q4)
12-31
2017 (Q3)
09-30
2017 (Q2)
06-30
2017 (Q1)
03-31
2016 (Q4)
12-31
2016 (Q3)
09-30
2016 (Q2)
06-30
2016 (Q1)
03-31
2015 (Q4)
12-31
2015 (Q3)
09-30
2015 (Q2)
06-30
2015 (Q1)
03-31
Report Filing: 2025-11-06 2025-11-06 2025-08-06 2025-05-06 2025-02-21 2024-11-07 2024-08-06
1234
Net Income/Starting Line 45.91 -39.34 -34.77 -11.65 131.7 -33.21 -30.62
1234
Cash From Operating Activities 65.47 -1.94 -28.78 125.4 -29.18 -27.86 268.6
1234
Depreciation and Amortization 1.44 0.361 0.304 0.239 0.536 0.647 0.892
1234
Deferred Income Tax 0 0 0 0 0 0 0
1234
Stock Based Compensation 33.81 0 10.91 13.8 9.09 10.16 0
1234
Other Non-Cash Items 3.16 8.98 -1.35 -1.72 -2.76 -2.84 7.28
1234
Changes in Working Capital -18.85 28.06 -3.88 124.7 -167.7 -2.63 291.1
1234
Accounts Receivable -0.045 -0.583 0.538 165 -165 0.043 300
1234
Inventory 0 0 0 0 0 0 0
1234
Accounts Payable 2.6 2.42 0.375 1.24 -1.43 -0.355 -0.201
1234
Deferred Revenue -21.4 26.23 -4.79 -41.55 -1.29 -2.31 -8.73
1234
Other Working Capital 0 0 0 0 0 0 0
1234
Cash From Investing Activities -106.9 -58.55 54.81 -94.4 -8.72 -208.7 -88.12
1234
Investments in Property Plant and Equipment -1.76 -0.088 -0.813 -0.545 -0.31 -0.775 -0.028
1234
Payments for Acquisitions 0 0 0 0 0 0 0
1234
Purchases of Securities -556.7 -161.1 -67.15 -214 -114.4 -266.7 -175
1234
Sales and Maturities of Investments 451.6 102.7 122.8 120.2 106 58.73 86.86
1234
Other Investing Activities -0.005 0 -0.005 0 0 0 0
1234
Cash From Financing Activities 24.06 5.66 2.92 11.44 4.03 12.05 2.57
1234
Debt Repayment 0 0 0 0 0 0 0
1234
Common Stock Issued 20.51 5.66 2.92 11.92 0 12.05 2.57
1234
Common Stock Repurchased 0 0 0 0 0 0 0
1234
Dividends Paid 0 0 0 0 0 0 0
1234
Other Financing Activities 3.55 0 0 -0.479 4.03 0 0
1234
Effect of Forex Changes on Cash 0.003 0.003 0 0 0 0 0
1234
Net Change in Cash 16.24 -54.83 28.95 42.4 -33.87 -224.5 183.1
1234
Cash at Beginning of Period 97.47 168.5 139.9 97.25 131.3 355.6 172.6
1234
Cash at End of Period 113.7 113.7 168.8 139.7 97.47 131.1 355.6
1234
Free Cash Flow 63.71 -2.02 -29.59 124.8 -29.49 -28.64 268.6
1234
Operating Cash Flow 65.47 -1.94 -28.78 125.4 -29.18 -27.86 268.6
1234
Capital Expenditure -1.76 -0.088 -0.813 -0.545 -0.31 -0.775 -0.028
1234
discounting cash flows home logo

Discounting Cash Flows

Are you finding our services helpful? Review us on trustpilot logo Trustpilot
Have a question? Contact us
Want to become our sponsor?
Check out our Affiliate Program